LIPOFEN Drug Patent Profile
✉ Email this page to a colleague
When do Lipofen patents expire, and what generic alternatives are available?
Lipofen is a drug marketed by Cipher Pharms Inc and is included in one NDA.
The generic ingredient in LIPOFEN is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lipofen
A generic version of LIPOFEN was approved as fenofibrate by RHODES PHARMS on May 13th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIPOFEN?
- What are the global sales for LIPOFEN?
- What is Average Wholesale Price for LIPOFEN?
Summary for LIPOFEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 138 |
Clinical Trials: | 3 |
Patent Applications: | 3,528 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LIPOFEN |
What excipients (inactive ingredients) are in LIPOFEN? | LIPOFEN excipients list |
DailyMed Link: | LIPOFEN at DailyMed |
![LIPOFEN drug patent expirations Drug patent expirations by year for LIPOFEN](/p/graph/s/t/LIPOFEN-patent-expirations.png)
![Drug Prices for LIPOFEN](/p/graph/drug-price/LIPOFEN.png)
![Drug Sales Revenue Trends for LIPOFEN](/p/graph/drug-sales-revenues/LIPOFEN.png)
US Patents and Regulatory Information for LIPOFEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-001 | Jan 11, 2006 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-002 | Jan 11, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-003 | Jan 11, 2006 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LIPOFEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-001 | Jan 11, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-003 | Jan 11, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-002 | Jan 11, 2006 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LIPOFEN
See the table below for patents covering LIPOFEN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2210985 | COMPOSITION PHARMACEUTIQUE CONTENANT DU FENOFIBRATE ET DES GLYCERIDES POLYGLYCOLYSES (PHARMACEUTICAL COMPOSITION CONTAINING FENOFIBRATE AND POLYGLYCOLIZED GLYCERIDES) | ⤷ Sign Up |
Spain | 2200048 | ⤷ Sign Up | |
European Patent Office | 0801562 | COMPOSITION PHARMACEUTIQUE CONTENANT DU FENOFIBRATE ET DES GLYCERIDES POLYGLYCOLYSES (PHARMACEUTICAL COMPOSITION CONTAINING FENOFIBRATE AND POLYGLYCOLIZED GLYCERIDES) | ⤷ Sign Up |
Japan | H10511959 | ⤷ Sign Up | |
Australia | 4380896 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |